Losartan attenuates myocardial ischemia-induced ventricular arrhythmias and reperfusion injury in spontaneously hypertensive rats

American Journal of Hypertension

Volumn 10, Issue 8, 1997, Pages 852-858

  Lee, Yen Mei ^a   Peng, Yen Yen ^a   Ding, Yu An ^b   Yen, Mao Hsiung ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Arrhythmia; Infarct; Losartan; Myocardial ischemia; Reperfusion injury; Spontaneously hypertensive rat

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN; NITROBLUE TETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; MALE; MEAN ARTERIAL PRESSURE; NITROBLUE TETRAZOLIUM TEST; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; SPONTANEOUSLY HYPERTENSIVE RAT;

ACUTE DISEASE; ANGIOTENSIN II; ANIMALS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; BLOOD PRESSURE; HEART RATE; HEMODYNAMIC PROCESSES; LOSARTAN; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, INBRED SHR; RECEPTORS, ANGIOTENSIN;

EID: 0030828870     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(97)00119-2     Document Type: Article

References (39)

1. Paul M, Bachmann J, Ganten D: The tissue renin-angiotensin systems in cardiovascular disease. Trends Cardiovasc Med 1992;2:94-99.
2. Xiang JZ, Scholkens BA, Ganten D, Unger T: Effects of sympathetic nerve stimulation are attenuated by the converting enzyme inhibitor Hoe 498 in isolated rabbit hearts. Clin Exp Hypertens 1984;6:1853-1857.
3. Xiang JZ, Linz W, Becker H, et al: Effects of converting enzyme inhibitors: ramipril and enalapril on peptide action and sympathetic neurotransmission in the isolated heart. Eur J Pharmacol 1985;113:215-223.
4. Saito K, Gutkind JS, Saavedra JM: Angiotensin II binding sites in the conduction system of rat hearts. Am J Physiol 1987;253:H1618-1622.
5. Rogers TB, Gaa ST, Allen IS: Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmcol Exp Ther 1986;236: 438-444.
6. Dostal DE, Baker KM: Evidence for a role of an intracardiac renin-angiotensin system in normal and failing hearts. Trends Cardiovasc Med 1993;3:67-74.
7. Smith RD, Chiu AT, Wong PC, et al: Pharmacology of nonpeptide angiotensin II receptor antagonists. Annu Rev Pharmacol Toxicol 1992;32:135-165.
8. Bumpus FM, Catt KJ, Chiu AT, et al: Nomenclature for angiotensin receptors. Hypertension 1991;17:720-721.
9. Wong PC, Price WA, Jr., Chiu AT, et al: Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Hypertension 1990;15: 459-468.
10. Fleetwood G, Boutinet S, Meier M, Wood JM: Involvement of the renin-angiotensin system in ischemic damage and reperfusion arrhythmias in the isolated perfused rat heart. J Cardiovasc Pharmacol 1991;17:351-356.
11. Jaiswal N, Diz DI, Tallant EA, et al: The nonpeptide angiotensin II antagonist DuP 753 is a potent stimulus for prostacyclin synthesis. Am J Hypertens 1991;4:228-233.
12. Alderman MH, Madhavan S, Ooi WL, et al: Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991;324:1098-1104.
13. Meade TW, Cooper JA, Peart WS: Plasma renin activity and ischemic heart disease. N Engl J Med 1993;329:616-619.
14. Thoren P: Evidence for a depressor reflex elicited from left ventricular receptors during occlusion of one coronary artery in the cat. Acta Physiol Scand 1973;88:23-34.
15. Peterson DF, Bishop VS: Reflex blood pressure control during acute myocardial ischemia in the conscious dog. Circ Res 1974;34:226-232.
16. Davis JO, Freeman RH: Mechanisms regulating renin release. Physiol Rev 1976;56:1-56.
17. Abrahamsson T, Almgren O, Carlsson L: Ischemia-induced local release of myocardial noradrenaline. J Cardiovasc Pharmacol 1985;7(suppl 5):S19-22.
18. Schomig A, Fischer S, Kurz T, et al: Nonexocytotic release of endogenous noradrenaline in the ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ Res 1987;60:194-205.
19. Lombardi F, Verrier RL, Lown B: Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion. Am Heart J 1983;105: 958-965.
20. Zaza A, Schwartz PJ: Role of the autonomic nervous system in the genesis of early ischemic arrhythmias. J Cardiovasc Pharmacol 1985;7(suppl 5):S8-S12.
21. Belardinelli L, Isenberg G: Actions of adenosine and isoprenaline on isolated mammalian ventricular myocytes. Circ Res 1983;53:287-297.
22. Fedida D, Noble D, Rankin AC, Spindler AJ: The arrhythmogenic transient inward current ITi and related contraction in isolated guinea pig ventricular myocytes. J Physiol 1987;392:523-542.
23. Reid IA: Actions of angiotensin II on the brain: mechanisms and physiologic role. Am J Physiol 1984;246: F533-543.
24. Reit E: Actions of angiotensin on the adrenal medulla and autonomic ganglia. Fed Proc 1972;31:1338-1343.
25. Starke K: Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol 1977;77:1-124.
26. Zimmerman BG: Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci 1981;60:343-348.
27. 1) receptor antagonist, attenuates pressor and sympathoexcitatory responses evoked by angiotensin II and L-glutamate in rostral ventrolateral medulla. Brain Res 1994; 665:245-252.
28. Hartman JC, Hullinger TB, Wall TM, Shebuski RJ: Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition. Eur J Pharmacol 1993;234:229-236.
29. Hartman JC: The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors. Ann Thorac Surg 1995;60:789-792.
30. Liu YH, Yang XP, Sharov VG, Sigmon DH, Sabbath HN, Carretero OA: Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 1996;27:7-13.
31. 2 receptors in endothelial cells and isolated ischemic rat hearts. J Hypertens 1993;11(suppl 5):S234-235.
32. Seyedi N, Xu X, Nasjletti A, Hintze TH: Coronary kinin generation mediates nitric doxide release after angiotensin receptor stimulation. Hypertension 1995;26:164-170.
33. Guidi E, Hollenberg NK: Differential pressor and renal vascular reactivity to angiotensin II in spontaneously hypertensive and Wistar Kyoto rats. Hypertension 1987;9:591-597.
34. Radhakrishnan R, Sim MK: Enhanced pressor response to angiotensin III in spontaneously hypertensive rats: effects of losartan. Eur J Pharmacol 1994;259:87-90.
35. Goldstein DS: Plasma catecholamines in clinical studies of cardiovascular diseases. Acta Physiol Scand Suppl 1984;527:39-41.
36. Peach MJ: Molecular actions of angiotensin. Biochem Pharmacol 1981;30:2745-2751.
37. Bernier M, Hearse DJ, Manning AS: Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res 1986;58:331-340.
38. Gavras H, Kremer D, Brown JJ, et al: Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J 1975;89:321-332.
39. Giacomelli F, Anversa P, Wiener J: Effect of angiotensin-induced hypertension on rat coronary arteries and myocardium. Am J Pathol 1976;84:111-138.